Nanotech Investing Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
Nanotech Investing Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
Nanotech Investing Soleno Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on U.S. Launch of VYKAT XR
Nanotech Investing Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET
Nanotech Investing Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
SAGA Metals Completes Phase 2 of Major Drill Program at the Radar Project in Labrador-Confirms Extensive Oxide Mineralization in All Drill Locations at Trapper North and South Zones & Provides Corporate Update
